Intranasal Steroid and Asthma
Journal: Journal of Pediatrics & Child Care (Vol.3, No. 2)Publication Date: 2017-12-31
Authors : Rajatsubhra Mukhopadhyay;
Page : 1-6
Keywords : Intranasal steroid therapy; Asthma; Atopy; On demand intranasal steroid therapy (ODIST); Eco nomy under developed country;
Abstract
A non randomized, active controlled trial was done and still is open to recruitment, open label, phase-1 type among few children over two years of age with positive history of atopy, WALRI & asthma, with intranasal steroid. Intranasal steroid was given in each side of nose with a phial then to follow On Demand Steroid Therapy [ODIST] was advised. Result was noted with their Symptoms Record Book, PEFR, Spirometry & IgE level.
Objectives were to see its outcome. And its' RR = 1.2, OR = 2. P = 0.02275, [DF = 1, CI = 1.026- 4.203 at 95%]. This can not only help the patients & parents but also have a great impact on the future economy of under developed country.
Other Latest Articles
- Intolerance to Prone Positioning as a Clinical Marker of Motor Delay in Infants
- Radiological and ClinicalFeatures of Vein of Galen Aneurysmal Malformation in Newborn Infants and, the Results of Endovascular Interventional Treatment: 10-Years Experience
- Idiopathic Infantile Arterial Calcification: A Case Report
- Schizencéphaly, a Rare Case in Ebolowa Regional Hospital, South Cameroon
- Antioxidants-the Miraculous Molecules
Last modified: 2017-12-08 16:15:48